Form 4: John Paulson Acquires Bausch Health Shares
Statement of Changes in Beneficial Ownership
John Paulson, a director at Bausch Health Companies Inc., acquired 12,677 common shares through restricted stock units.
Summary
- John Paulson, a director of Bausch Health Companies Inc. (BHC), acquired 12,677 common shares on June 30, 2026.
- These shares were issued as Restricted Share Units (RSUs) in lieu of cash compensation for his board service during the quarter ending June 30, 2026.
- Each RSU represents a contingent right to receive one common share of BHC.
- Following this transaction, Paulson's direct beneficial ownership is 12,677 shares.
- Additionally, Paulson may be deemed an indirect beneficial owner of 73,255,869 shares held by investment funds managed by Paulson Capital Inc., where he is the controlling person.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine director compensation and indirect beneficial ownership, without new strategic information or significant changes in direct holdings.
Positives
- Director compensation in the form of equity (RSUs) aligns management interests with shareholders.
- Acquisition of shares by a director can signal confidence in the company's future prospects.
- Significant indirect beneficial ownership by Paulson's managed funds indicates substantial investment in BHC.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those involving directors, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance. The issuance of RSUs as compensation is a common practice in the pharmaceutical and healthcare sectors.
Stakeholder Impact
- Shareholders: The issuance of RSUs as compensation is a standard practice, but the scale of indirect ownership by Paulson's funds may influence market perception.
- Employees: Indirectly impacted by the company's performance, which insider transactions may signal.
- Management: The use of RSUs aligns director compensation with company performance.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Transaction Date for acquisition of common shares via RSUs. |
| 07/02/2026 | Signature Date for the Form 4 filing. |
Keywords
Bausch Health Companies, BHC, John Paulson, Form 4, Insider Trading, Restricted Share Units, Director Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.